Tia L. Bush - 16 Nov 2021 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Quality Officer
Signature
/s/ Marella Thorell, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
16 Nov 2021
Net transactions value
+$62,302
Form type
4
Filing time
18 Nov 2021, 18:00:17 UTC
Previous filing
04 Jun 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Purchase $12,040 +995 +33% $12.10 3,995 16 Nov 2021 By spouse F1
transaction CNTA Ordinary Shares Purchase $50,263 +4,005 +100% $12.55 8,000 16 Nov 2021 By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.